Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases.
To contact Derek email him directly: derekb.lowe@gmail.com
Twitter: Dereklowe
Let's Just Spread This Deal Out All Over the Paper, Why Don't We?
Posted by Derek
Fierce Biotech has it right - the management at Sanofi-Aventis is "leaking like an old wooden ship". That's why we're seeing so many reports from highly placed sources, and people familiar with the negotiations, and so on. Here's the latest, and no doubt phones are even at this moment ringing over at the Wall Street Journal and Bloomberg with updates. . .
According to the below report, Biotech employment has increased by 50% in the last three years. Can't say I've seen any of these ghost companies advertising. Time to open the immigration floodgates as shortages must be occurring!
These leaks have to be a strategy of Sanofi. Think about some of the other big mergers, Pfizer/Pharmacia, Pfizer/Wyeth, Merck/SP, never a peep until it was announced!
Since Icahn has been livid over Genzyme's performance as of late, I wonder if he has a hand in this?
1. Garnet on July 29, 2010 7:55 PM writes...
According to the below report, Biotech employment has increased by 50% in the last three years. Can't say I've seen any of these ghost companies advertising. Time to open the immigration floodgates as shortages must be occurring!
"Biotech employment grew despite downturn"
http://philadelphia.bizjournals.com/philadelphia/stories/2010/07/26/daily29.html
Permalink to Comment2. LAM on July 29, 2010 8:26 PM writes...
Remember, Chris Viehbacher came from SB / GSK and seems to be working to the same standard here.
Permalink to Comment3. Mark on July 30, 2010 7:56 AM writes...
These leaks have to be a strategy of Sanofi. Think about some of the other big mergers, Pfizer/Pharmacia, Pfizer/Wyeth, Merck/SP, never a peep until it was announced!
Since Icahn has been livid over Genzyme's performance as of late, I wonder if he has a hand in this?
Mark
Permalink to Comment4. Anonymous on August 1, 2010 3:09 PM writes...
And from a local NJ, USA standpoint, I heard that there was a ca. 50% (yes 50%) reduction in their chemistry staff at their NJ site. Sad, very sad....
Permalink to Comment